Publications

• Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report.

  (Durazo FA, Nicholas AA, Mahaffey JJ, Sova S, Evans JJ, Trivella JP, Loy V, Kim J, Zimmerman MA, Hong JC.) Transplant Proc. 2021 Mar 12 PMID: 33846012 PMCID: PMC7953456 SCOPUS ID: 2-s2.0-85103958333 04/14/2021

• Dietary Protein, Fiber and Coffee Are Associated with Small Intestine Microbiome Composition and Diversity in Patients with Liver Cirrhosis.

  (Hussain SK, Dong TS, Agopian V, Pisegna JR, Durazo FA, Enayati P, Sundaram V, Benhammou JN, Noureddin M, Choi G, Ayoub WS, Lagishetty V, Elashoff D, Goodman MT, Jacobs JP.) Nutrients. 2020 May 13;12(5) PMID: 32414035 PMCID: PMC7285216 05/18/2020

• Long-term outcomes with oral therapy in liver transplant recipients with hepatitis B.

  (Saab S, Song D, Challita YP, Xiwen Zhou T, Saab EG, Viramontes MR, Choi G, Durazo FA, Han SB, El Kabany MM, Jackson NJ, Busuttil RW.) Clin Transplant. 2019 12;33(12):e13740 PMID: 31651048 10/28/2019

• Elimination of Hepatitis C in Liver Transplant Recipients.

  (Saab S, Challita Y, Chen PH, Jimenez MA, Lee AD, Saab EG, Ahn T, Choi G, Durazo FA, El-Kabany MM, Han SB, Grotts J, Agopian VG, Busuttil RW.) J Clin Transl Hepatol. 2018 Sep 28;6(3):247-250 PMID: 30271735 PMCID: PMC6160303 10/03/2018

• Impact of Sustained Viral Response With Direct-Acting Agents on Glycemic Control and Renal Function in Hepatitis C Liver Transplant Recipients.

  (Saab S, Barnard A, Challita Y, Adeniyi A, Aziz A, Choi G, Durazo FA, El-Kabany MM, Han SB, Busuttil RW.) Exp Clin Transplant. 2018 08;16(4):419-424 PMID: 30060729 08/01/2018

• Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C.

  (Saab S, Rheem J, Jimenez MA, Fong TM, Mai MH, Kachadoorian CA, Esmailzadeh NL, Bau SN, Kang S, Ramirez SD, Grotts J, Choi G, Durazo FA, El-Kabany MM, Han SB, Busuttil RW.) J Clin Transl Hepatol. 2017 Jun 28;5(2):101-108 PMID: 28660147 PMCID: PMC5472930 07/01/2017

• Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals.

  (Nguyen K, Jimenez M, Moghadam N, Wu C, Farid A, Grotts J, Elashoff D, Choi G, Durazo FA, El-Kabany MM, Han SB, Saab S.) J Clin Transl Hepatol. 2017 Mar 28;5(1):43-49 PMID: 28507926 PMCID: PMC5411356 05/17/2017

• Use of Sofosbuvir-Based Treatment of Chronic Hepatitis C in Liver Transplant Recipients on Hemodialysis.

  (Saab S, A Jimenez M, N Bau S, Choi G, Durazo FA, M El-Kabany M, Han SB, Busuttil RW.) J Clin Gastroenterol. 2017 Feb;51(2):167-173 PMID: 27548734 08/23/2016

• Limited Knowledge of Acetaminophen in Patients with Liver Disease.

  (Saab S, Konyn PG, Viramontes MR, Jimenez MA, Grotts JF, Hamidzadah W, Dang VP, Esmailzadeh NL, Choi G, Durazo FA, El-Kabany MM, Han SB, Tong MJ.) J Clin Transl Hepatol. 2016 Dec 28;4(4):281-287 PMID: 28097095 PMCID: PMC5225146 01/18/2017

• Intraductal Cooling via a Nasobiliary Tube During Radiofrequency Ablation of Central Liver Tumors Reduces Biliary Injuries.

  (Felker ER, Lee-Felker SA, Ajwichai K, Tan N, Lu DS, Durazo FA, Raman SS.) AJR Am J Roentgenol. 2015 Jun;204(6):1329-35 PMID: 26001245 05/23/2015

• Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center.

  (Hong JC, Jones CM, Duffy JP, Petrowsky H, Farmer DG, French S, Finn R, Durazo FA, Saab S, Tong MJ, Hiatt JR, Busuttil RW.) Arch Surg. 2011 Jun;146(6):683-9 PMID: 21690444 SCOPUS ID: 2-s2.0-79959342683 06/22/2011

• Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma.

  (Hong JC, Petrowsky H, Kaldas FM, Farmer DG, Durazo FA, Finn RS, Saab S, Han SH, Lee P, Markovic D, Lassman C, Hiatt JR, Busuttil RW.) J Am Coll Surg. 2011 Apr;212(4):514-20; discussion 520-1 PMID: 21463781 SCOPUS ID: 2-s2.0-79953784805 04/06/2011